These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 4985092)

  • 1. Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas.
    Menon IA; Haberman HF
    Arch Biochem Biophys; 1970 Mar; 137(1):231-42. PubMed ID: 4985092
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of tyrosinase activity in mouse melanoma and skin by changes in melanosomal membrane permeability.
    Van Woert MH; Korb F; Prasad KN
    J Invest Dermatol; 1971 May; 56(5):343-8. PubMed ID: 4997370
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
    Tomita Y; Hariu A; Kato C; Seiji M
    Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosinase activity of melanosomes from the Harding-Passey melanoma: the absence of a peroxidase component in vitro.
    Mufson RA
    Arch Biochem Biophys; 1975 Apr; 167(2):738-43. PubMed ID: 804863
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of phenothiazines on melanoma tyrosinase activity.
    Van Woert MH
    J Pharmacol Exp Ther; 1970 Jun; 173(2):256-64. PubMed ID: 4988494
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
    Hamada T; Mishima Y
    Br J Dermatol; 1972 Apr; 86(4):385-94. PubMed ID: 4623455
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosinase activity in subcellular fractions of black and albino mice.
    Hearing VJ
    Nat New Biol; 1973 Sep; 245(142):81-3. PubMed ID: 4199613
    [No Abstract]   [Full Text] [Related]  

  • 9. A modified method for the isolation of melanosomes from B16 melanoma.
    Haberman HF; Menon IA
    J Invest Dermatol; 1973 Feb; 60(2):67-72. PubMed ID: 4348133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structural factors and the DOPA oxidase activity of membrane-bound tyrosinase].
    Shtol'ko VN; Kol'tover VK; Il'in AV; Vasil'eva LS; Bogdanov GN
    Dokl Akad Nauk SSSR; 1979; 244(4):1009-12. PubMed ID: 104854
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of peroxidase vs. the role of tyrosinase in enzymatic conversion of tyrosine to melanin in melanocytes, mast cells and eosinophils.
    Okun MR; Edelstein LM; Or N; Hamada G; Donnellan B
    J Invest Dermatol; 1970 Jul; 55(1):1-12. PubMed ID: 4987505
    [No Abstract]   [Full Text] [Related]  

  • 12. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinase in melanized melanosomes.
    Seiji M; Fukuzawa H
    Tohoku J Exp Med; 1972 Nov; 108(3):291-302. PubMed ID: 4197851
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of x-irradiation on melanosomal tyrosinase activity.
    Van Woert MH; Korb F
    Radiat Res; 1973 Mar; 53(3):435-43. PubMed ID: 4633182
    [No Abstract]   [Full Text] [Related]  

  • 15. Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
    Edelstein LM; Cariglia N; Okun MR; Patel RP; Smucker D
    J Invest Dermatol; 1975 May; 64(5):364-70. PubMed ID: 806638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
    García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
    Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.
    Lee TH; Lee MS; Lu MY
    Endocrinology; 1972 Nov; 91(5):1180-8. PubMed ID: 4627367
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigation of tyrosinase activity and phospholipid composition in Harding-Passey melanoma microsomal fraction].
    Shtol'ko VN; Bogdanov GN; Vasil'eva LS; Burlakova EB
    Biokhimiia; 1978 Jan; 43(1):121-6. PubMed ID: 414789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH; Lee MS
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subcellular distribution of lysosomal hydrolases in the Harding-Passey melanoma.
    Mufson RA
    J Cell Physiol; 1974 Feb; 83(1):75-83. PubMed ID: 4204977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 57.